Literature DB >> 23252710

Outcomes of cardiac resynchronization therapy in the elderly.

Ammar M Killu1, Jia-Hui Wu, Paul A Friedman, Win-Kuang Shen, Tracy L Webster, Kelly L Brooke, David O Hodge, Heather J Wiste, Yong-Mei Cha.   

Abstract

BACKGROUND: Octogenarians (>80 years) have been underrepresented in clinical trials of cardiac resynchronization therapy (CRT).
OBJECTIVE: To determine the benefit of CRT with or without a defibrillator in older elderly patients.
METHODS: We retrospectively studied consecutive patients who received CRT at our institution from 2002 through 2008. New York Heart Association (NYHA) class and echocardiographic parameters were assessed before and after CRT. Thirty-day complications after device implant were collected. Survival data were obtained from the national death and location database. Data were compared between those 80 years and younger and those older than 80 years.
RESULTS: Of 728 patients identified, 90 (12.4%) were older than 80 years. After CRT, older and younger patients had similar improvements in NHYA class (P = 0.41), ejection fraction (P = 0.48), and mitral valve regurgitation (MR) severity (P = 0.42). In the older patients, defibrillator implantation was associated with comparable improvement in NYHA class, ejection fraction, and MR grade severity (P > 0.05), as in those without a defibrillator. Overall survival was worse in octogenarians than in the younger patients by Kaplan-Meier estimates (P = 0.001). Multivariate analysis showed similar survival between the younger and older subjects (hazard ratio, 1.23; 95% confidence interval, 0.83-1.84; P = 0.31). The observed complication rate in all study subjects was 12.2%, with no difference between the two age groups.
CONCLUSION: Octogenarian patients who received CRT with or without a defibrillator for advanced heart failure had similar clinical benefits as younger patients. CRT should not be withheld from octogenarians meeting current selection guidelines. ©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23252710     DOI: 10.1111/pace.12048

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  15 in total

1.  Comparison of pharmacological treatment alone versus treatment combined with cardiac resynchronization therapy in patients over 75 years.

Authors:  Elena de la Cruz; Marcelino Cortés; Jerónimo Farré; Julia Palfy; Paloma Ávila; Ignacio Hernández; Angélica Romero; Juan Benezet; Juan Antonio Franco; Miguel Angel Navas; Jose Joel Hernandez; Sem Briongos; José M Rubio
Journal:  J Interv Card Electrophysiol       Date:  2015-02-17       Impact factor: 1.900

Review 2.  Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.

Authors:  Pow-Li Chia; David Foo
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

Review 3.  Device Management in Heart Failure.

Authors:  Brett G Angel; Heath Saltzman; Luke S Kusmirek
Journal:  Curr Cardiol Rep       Date:  2017-09-25       Impact factor: 2.931

Review 4.  Arrhythmias in Patients ≥80 Years of Age: Pathophysiology, Management, and Outcomes.

Authors:  Anne B Curtis; Roshan Karki; Alexander Hattoum; Umesh C Sharma
Journal:  J Am Coll Cardiol       Date:  2018-05-08       Impact factor: 24.094

5.  National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010.

Authors:  Jersey Chen; Angela Fu-Chi Hsieh; Kumar Dharmarajan; Frederick A Masoudi; Harlan M Krumholz
Journal:  Circulation       Date:  2013-11-04       Impact factor: 29.690

6.  National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator.

Authors:  Charlotta Lindvall; Neal A Chatterjee; Yuchiao Chang; Betty Chernack; Vicki A Jackson; Jagmeet P Singh; Joshua P Metlay
Journal:  Circulation       Date:  2015-12-03       Impact factor: 29.690

7.  Intermediate-term mortality and incidence of ICD therapy in octogenarians after cardiac resynchronization therapy.

Authors:  Heval Mohamed Kelli; Faisal M Merchant; Andenet Mengistu; Mary Casey; Michael Hoskins; Mikhael F El-Chami
Journal:  J Geriatr Cardiol       Date:  2014-09       Impact factor: 3.327

8.  Cardiac resynchronization in the elderly is beneficial, but could we implant our devices in old patients safer?

Authors:  Evgeny N Mikhaylov; Dmitry S Lebedev
Journal:  J Geriatr Cardiol       Date:  2016-03       Impact factor: 3.327

9.  Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly?

Authors:  Bartosz Olechowski; Rebecca Sands; Donah Zachariah; Neil P Andrews; Richard Balasubramaniam; Mark Sopher; John Paisey; Paul R Kalra
Journal:  J Geriatr Cardiol       Date:  2015-09       Impact factor: 3.327

10.  Clinical outcomes of cardiac resynchronization therapy with and without a defibrillator in elderly patients with heart failure.

Authors:  Simon Christie; Brett Hiebert; Colette M Seifer; Clarence Khoo
Journal:  J Arrhythm       Date:  2018-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.